We are live on ! Find out more
AI

Acuitas Investments Portfolio holdings

AUM $1.43M
1-Year Est. Return 17.52%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+17.52%
3 Year Est. Return
+145.17%
5 Year Est. Return
+267.61%
10 Year Est. Return
AUM
$172M
AUM Growth
+$74.9M
Cap. Flow
+$68.2M
Cap. Flow %
39.75%
Top 10 Hldgs %
25.97%
Holding
117
New
76
Increased
14
Reduced
9
Closed
11

Sector Composition

Rank Sector Weight
1 Industrials 17.31%
2 Healthcare 16.15%
3 Technology 13.93%
4 Consumer Discretionary 13.04%
5 Consumer Staples 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BOLT icon
76
Bolt Biotherapeutics
BOLT
$7.78M
$589K 0.34%
+23,019
New +$731K
SERA icon
77
Sera Prognostics
SERA
$81.1M
$571K 0.33%
+173,202
New +$594K
NUVB icon
78
Nuvation Bio
NUVB
$2.32B
$570K 0.33%
+316,517
New +$538K
KRON
79
DELISTED
Kronos Bio
KRON
$566K 0.33%
+328,833
New +$522K
LTCH
80
DELISTED
Latch, Inc. Common Stock
LTCH
$556K 0.32%
+400,072
New +$374K
AXR icon
81
AMREP Corp
AXR
$119M
$554K 0.32%
+30,907
New +$467K
CMRX
82
DELISTED
Chimerix, Inc.
CMRX
$554K 0.32%
+457,817
New +$580K
OMIC
83
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$549K 0.32%
+22,063
New +$646K
NXTC icon
84
NextCure
NXTC
$26.7M
$516K 0.3%
+23,903
New +$471K
LENZ
85
LENZ Therapeutics
LENZ
$168M
$509K 0.3%
+27,967
New +$559K
LUMO
86
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$508K 0.3%
+153,867
New +$543K
RFL icon
87
Rafael Holdings
RFL
$107M
$488K 0.28%
+236,692
New +$472K
PRDS
88
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$482K 0.28%
+266,061
New +$486K
TATT icon
89
TAT Technologies
TATT
$515M
$478K 0.28%
+63,936
New +$406K
AVIR icon
90
Atea Pharmaceuticals
AVIR
$420M
$462K 0.27%
+123,430
New +$462K
SHPW
91
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
$449K 0.26%
+119,511
New +$371K
FULC icon
92
Fulcrum Therapeutics
FULC
$297M
$445K 0.26%
+134,815
New +$396K
AIP icon
93
Arteris
AIP
$1.38B
$439K 0.26%
+64,353
New +$348K
NKTR icon
94
Nektar Therapeutics
NKTR
$2.58B
$415K 0.24%
+48,100
New +$513K
PASG icon
95
Passage Bio
PASG
$14.1M
$394K 0.23%
+20,909
New +$414K
CKX icon
96
CKX Lands
CKX
$21.7M
$332K 0.19%
+33,279
New +$328K
METCB icon
97
Ramaco Resources Class B
METCB
$408M
$304K 0.18%
+30,884
New +$298K
DBTX
98
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$162K 0.09%
+41,960
New +$154K
BTG icon
99
B2Gold
BTG
$6.64B
$111K 0.06%
+31,000
New +$121K
FTI icon
100
TechnipFMC
FTI
$27.3B
$89.6K 0.05%
+5,394
New +$76K

Similar funds

Acuitas Investments's Q2 2023 Portfolio in Review

As of Q2 2023, Acuitas Investments held 117 positions worth $172M, up 77% from $96.8M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Acuitas Investments deployed $68.2M of net new capital in Q2 2023, opening 76 new positions and adding to 14 existing holdings. Its largest new stake was AngioDynamics: 371,800 shares worth $3.88M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $1.81M trimmed.

  • Acuitas Investments's largest Q2 2023 buy was AngioDynamics: 371,800 shares worth $3.88M.
  • Acuitas Investments added most to Natural Gas Services Group in Q2 2023, an estimated $1.27M increase.
  • Acuitas Investments's biggest Q2 2023 reduction was Chicos FAS, Inc., cutting an estimated $1.81M.
  • Acuitas Investments fully exited Controladora Vuela Compania de Aviacion in Q2 2023, selling an estimated $2.84M.
  • Acuitas Investments's ten largest holdings make up 26% of its $172M portfolio in Q2 2023.
  • Acuitas Investments opened 76 new positions and closed 11 in Q2 2023.
  • Acuitas Investments's portfolio value rose 77% quarter-over-quarter to $172M.

Based on Acuitas Investments's 13F filing for Q2 2023, filed 7 Aug 2023.